(Q83854049)
Statements
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors (English)
R Hoekstra
F Y F L de Vos
D R A Uges
A van der Gaast
H J M Groen
W J Loos
R A Knight
R A Carr
R A Humerickhouse